** Shares of Biocytogen Pharmaceuticals (Beijing) 2315.HK jump 9.6% to HK$30.58, their highest level since debut in September 2022, and on course for a second session of gains
** Stock set for the biggest one-day pct gain since September 18
** The China-based drug developer said on Wednesday the listing committee for the Sci-Tech Board of the Shanghai Stock Exchange has approved the company's plan to issue and listing of its A shares on the Sci-Tech Board in Shanghai
** YTD, stock up 258.6%, Hang Seng Biotech Index .HSBIO up 100.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))